Trials / Unknown
UnknownNCT01006668
Sevoflurane Versus Propofol for Intubation in Neonatal Intensive Care
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- 28 Days
- Healthy volunteers
- Not accepted
Summary
Endotracheal intubation is a painful and stressful procedure, which is associated with acute increases of blood pressure, intracranial pressure, bradycardia and hypoxemia with high morbidity. The aim of the study is to compare recovery time, efficacy and tolerance in a randomized controlled study, between sevoflurane and propofol for intubation in neonates in Neonatal Intensive Care Unit.
Detailed description
Background: Endotracheal intubation is a painful and stressful procedure, which is associated with acute increases of blood pressure, intracranial pressure, bradycardia and hypoxemia with hight morbidity. In 2001, in France more than 50% of intubations in neonates were performed without any premedication or anesthesia. The most frequently used anesthesias are based on benzodiazepine or opioids. Unfortunately, these treatments are responsible for respiratory and hemodynamic adverse effects. Recently, 2 new possibilities for anesthesia before intubation has been tested: propofol was better than association of morphine, succinylcholine and atropine and we shaw that inhaled sevoflurane was better than no treatment. The aim of the present study is to compare recovery time, efficacy and tolerance in a randomized controlled study, between sevoflurane and propofol for intubation in neonates in Neonatal Intensive Care Unit. Objectives: The objective of this study is to compare recovery time, efficacy and tolerance in a randomized controlled study, between sevoflurane and propofol for intubation of neonates. Methods: Prospective, controlled, randomized, monocentric study. Subjects: Neonates in neonatal intensive care requiring intubation. Evaluation criteria: Recovery time after intubation, facilitation of procedure, tolerance of treatment (mean arterial pressure, apnea).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Administration of sevoflurane | Administration of sevoflurane (SEVORANE) by inhalation until a maximal concentration of 4% of inspired gas. |
| DRUG | Administration of propofol | Administration of propofol (DIPRIVAN) by intravenous injection (1 mg/kg to turn over twice if necessary. |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2014-11-01
- First posted
- 2009-11-03
- Last updated
- 2014-08-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01006668. Inclusion in this directory is not an endorsement.